[Atopic dermatitis and tacrolimus in adults]

Area of Science:

• Dermatology
• Immunology
• Pharmacology

Context:

• Atopic dermatitis (AD) is a chronic inflammatory skin condition affecting adults and children.
• Current treatments include topical corticosteroids, which have varying efficacy and side effect profiles.
• Tacrolimus offers a non-steroidal topical treatment option.

Purpose:

• To evaluate the efficacy and safety of topical tacrolimus in treating atopic dermatitis.
• To compare tacrolimus's effectiveness against placebo, low-potency corticosteroids, and other systemic/topical agents.
• To assess the side effect profile and systemic absorption of topical tacrolimus.

Summary:

• Topical tacrolimus demonstrates superior efficacy compared to placebo and low-potency topical corticosteroids for atopic dermatitis in both pediatric and adult populations.
• Its potency is comparable to medium-potency topical corticosteroids and shows greater effectiveness than topical pimecrolimus and oral cyclosporine.
• Tacrolimus is generally well-tolerated, with the most common side effect being a transient burning or itching sensation at the application site, which rarely leads to treatment discontinuation.

Impact:

• Provides evidence for topical tacrolimus as a highly effective treatment for atopic dermatitis.
• Highlights the favorable safety profile of topical tacrolimus, with no significant systemic absorption or increased risk of skin infections or neoplasms.
• Offers a valuable alternative for managing atopic dermatitis, particularly for patients who do not respond well to or tolerate conventional therapies.